Status:
RECRUITING
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Breast Carcinoma
Lung Carcinoma
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screeni...
Detailed Description
PRIMARY OBJECTIVES: I. Determine the number of patients undergoing breast screening who are eligible to participate in lung screening. II. Determine whether patients currently participating in cance...
Eligibility Criteria
Inclusion
- Age:
- Breast screening \> 40
- Lung screening 50-80
- Male (M) or Female (F)
- Current, former, or never smokers
- Close family or friend with smoking history (in or out of state)
Exclusion
- Age:
- Breast screening \< 40
- Lung screening \< 50 or \> 80
- Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year will also be excluded
- Persons with an active cancer
Key Trial Info
Start Date :
July 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2029
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05978128
Start Date
July 28 2023
End Date
September 30 2029
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095